NEW: @Injective signs an MOU with @BDACSKorea to bring KRW1, a Korean won-backed stablecoin, to the network. This would let Korean investors and institutions access onchain markets in their own currency and settle trades directly in won, rather than having to convert to USD stablecoins. Eric Chen (@ericinjective), Co-founder and CEO of Injective, recently explained on @_TalkingTokens how being onchain changes access to capital: "The advantage of being onchain is the efficiency gain and also the ease of access to capital. If you want to invest in something, you have to go through a very, very long process filling out all the forms. Once you’re [onchain], you have access to a very broad plethora of asset offerings. So it’s kind of like a one and done deal. It’s just about identifying those who are denied or priced out of the traditional infrastructure, [and] bring them onchain."